-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TJF5dW0S0psYr3HmrX6RaYwa0/Fr4vGkppRZ6zWZyl+5s6XtX/D5pCQQ9JY1jDqj YeaFgPLVr54jsaoksUw63Q== 0000897069-10-000482.txt : 20100611 0000897069-10-000482.hdr.sgml : 20100611 20100611160635 ACCESSION NUMBER: 0000897069-10-000482 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100610 FILED AS OF DATE: 20100611 DATE AS OF CHANGE: 20100611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reimer Samuel R CENTRAL INDEX KEY: 0001476156 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 10892716 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 form4_samuelreimerex.xml X0303 4 2010-06-10 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001476156 Reimer Samuel R TWO BETHESDA METRO CENTER SUITE 1200 BETHESDA MD 20814 0 1 0 0 VP, Treasurer, Asst. Secretary Common Stock 2010-06-10 4 S 0 1268 16.7777 D 13094 D These shares were sold at a range of sales prices from $16.77 to $16.79. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares reported on Table I include (i) unvested restricted shares which total 7,000 shares of stock from an original grant of 7,000 shares of restricted stock made on March 30, 2010; (ii) unvested restricted shares that total 1,875 shares of stock from an original grant of 2,500 shares of restricted stock made on November 13, 2008; (iii) vested and unvested restricted shares that total 4,069 shares of stock from an original grant of 7,000 shares of restricted stock made on June 4, 2008; and (iv) 150 shares of common stock previously purchased by the reporting person on the open market. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Teri L. Champ, Attorney-in-Fact 2010-06-11 -----END PRIVACY-ENHANCED MESSAGE-----